BBH vs. ARKG
BBH (VanEck Vectors Biotech ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. BBH is passively managed, while ARKG is actively managed. Over the past 10 years, BBH returned 5.52%/yr vs 7.24%/yr for ARKG. A 0.71 correlation means they provide meaningful diversification when combined. BBH charges 0.35%/yr vs 0.75%/yr for ARKG.
Performance
BBH vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBH achieves a -3.98% return, which is significantly lower than ARKG's 17.36% return. Over the past 10 years, BBH has underperformed ARKG with an annualized return of 5.52%, while ARKG has yielded a comparatively higher 7.24% annualized return.
BBH
- 1D
- -2.26%
- 1M
- -0.77%
- YTD
- -3.98%
- 6M
- -6.02%
- 1Y
- 22.25%
- 3Y*
- 5.36%
- 5Y*
- 0.21%
- 10Y*
- 5.52%
ARKG
- 1D
- -2.16%
- 1M
- 12.21%
- YTD
- 17.36%
- 6M
- 14.32%
- 1Y
- 57.12%
- 3Y*
- 0.75%
- 5Y*
- -15.45%
- 10Y*
- 7.24%
BBH vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | -3.98% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.36% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
Correlation
The correlation between BBH and ARKG is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.66 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.72 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.72 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 2014 | 0.71 |
The correlation between BBH and ARKG shifts across timeframes, from 0.60 (1 year) to 0.72 (10 years), reflecting how their relationship changes across market environments.
BBH vs. ARKG - Sectors Allocation Comparison
Sectors
BBH
ARKG
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BBH
ARKG
Basic Materials
BBH
-
ARKG
-
Communication Services
BBH
-
ARKG
-
Consumer Cyclical
BBH
-
ARKG
-
Consumer Defensive
BBH
-
ARKG
-
Energy
BBH
-
ARKG
-
Financial Services
BBH
-
ARKG
Industrials
BBH
-
ARKG
-
Real Estate
BBH
-
ARKG
-
Technology
BBH
-
ARKG
-
Utilities
BBH
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBH vs. ARKG — Risk / Return Rank
BBH
ARKG
BBH vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | ARKG | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.18 | 1.40 | -0.21 |
Sortino ratioReturn per unit of downside risk | 1.77 | 2.08 | -0.31 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.23 | -0.03 |
Calmar ratioReturn relative to maximum drawdown | 2.19 | 2.27 | -0.08 |
Martin ratioReturn relative to average drawdown | 5.64 | 5.46 | +0.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBH | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.18 | 1.40 | -0.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | -0.34 | +0.35 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.25 | 0.18 | +0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.13 | +0.25 |
Drawdowns
BBH vs. ARKG - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for BBH and ARKG.
Loading charts...
Drawdown Indicators
| BBH | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -83.59% | +10.89% |
Max Drawdown (1Y)Largest decline over 1 year | -10.55% | -27.51% | +16.96% |
Max Drawdown (3Y)Largest decline over 3 years | -22.74% | -51.96% | +29.22% |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | -80.18% | +40.32% |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | -83.59% | +43.73% |
Current DrawdownCurrent decline from peak | -15.68% | -69.58% | +53.90% |
Average DrawdownAverage peak-to-trough decline | -20.75% | -35.86% | +15.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.10% | 11.46% | -7.36% |
Volatility
BBH vs. ARKG - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 5.79%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.89%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBH | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.79% | 11.89% | -6.10% |
Volatility (6M)Calculated over the trailing 6-month period | 14.21% | 29.12% | -14.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.91% | 41.24% | -22.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.47% | 45.62% | -24.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.16% | 41.13% | -18.97% |
BBH vs. ARKG - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
BBH vs. ARKG - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.53%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
BBH VanEck Vectors Biotech ETF | 0.53% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
Frequently Asked Questions
BBH and ARKG have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.89%) compared to BBH (5.79%). In terms of maximum drawdown, BBH dropped -72.70% vs ARKG's -83.59%.
On 10-year performance, ARKG leads with 7.24% vs 5.52% for BBH. On fees, BBH is cheaper at 0.35% per year. On volatility, BBH has been the lower-risk option at 5.79%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ARKG has performed better with a 7.24% return vs 5.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BBH is cheaper with a 0.35% expense ratio, compared with 0.75% for ARKG.
BBH has the higher dividend yield at 0.53%, compared with 0.00% for ARKG.
They also come from different issuers: VanEck and ARK. Their fees differ too: 0.35% for BBH and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.40 vs 1.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBH and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer